More data/info8 Jan 2025 08:28
According to todays Reach...
"The advances made by ImmuPharma with the P140 program, particularly in the latter part of 2024..."
What are these advances? why not give investors more information - I know companies often have good reason for keeping things close to the chest but why should I invest more than £1-2,000 in this or any other company unless they put more meat on the bones. If I was a journalist interviewing the company I would at least want to know how many people worked on these advances, who they were were - was it just one team or several - was all of the work in-house or was some research contracted out? How many hours were spent on them - is it a full or part-time project for the team - and what kind of work was done. I might be naive as an investor or pharma investor but I feel reluctant to part with more cash unless I am given more information. I will ask Roast (their PR) for more info when I have some free time. But I imagine they read this board. Well they should if IMM are paying them.